U.S., March 19 -- ClinicalTrials.gov registry received information related to the study (NCT06881173) titled 'The Effectiveness of Bu Zhong Yi Qi Tang in Patients with Myasthenia Gravis' on Aug. 06, 2024.
Brief Summary: Research Background: According to the Myasthenia Gravis Foundation of America (MGFA, 2015), the estimated prevalence of myasthenia gravis is 14-20 per 100,000 people, with a higher prevalence in young female individuals compared to males. However, as individuals age, especially after the age of 50, the prevalence in males becomes higher than in females. myasthenia gravis patients often experience varying degrees of disability, leading to the need for long-term medical care, medication, and lifestyle adjustments. This also g...